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Backbone-cyclized proteins are becoming increasingly well
known, although the mechanism by which they are processed from
linear precursors is poorly understood. In this report the sequence
and structure of the linear precursor of a cyclic trypsin inhibitor,
sunflower trypsin inhibitor 1 (SFTI-1) from sunflower seeds, is
described. The structure indicates that the major elements of the
reactive site loop of SFTI-1 are present before processing. This may
have importance for a protease-mediated cyclizing reaction as the
rigidity of SFTI-1 may drive the equilibrium of the reaction cata-
lyzed by proteolytic enzymes toward the formation of a peptide
bond rather than the normal cleavage reaction. The occurrence of
residues in the SFTI-1 precursor susceptible to cleavage by asparag-
inyl proteases strengthens theories that involve this enzyme in the
processing of SFTI-1 and further implicates it in the processing of
another family of plant cyclic proteins, the cyclotides. The precur-
sor reported here also indicates that despite strong active site
sequence homology, SFTI-1 has no other similarities with the Bow-
man-Birk trypsin inhibitors, presenting interesting evolutionary
questions.
Naturally occurring circular proteins are becoming increasingly well
known, with examples in bacteria, plants, and animals discovered over
recent years (1). These topologically interesting proteins have a contin-
uous cycle of peptide bonds in their backbone and, accordingly, are
devoid of N or C termini. Such proteins were unknown a decade ago,
and they differ from previously known cyclic peptides, such as the
immunosuppressant cyclosporin and other cyclic peptides found in
micro-organisms, in that they are conventional gene products rather
than the output of nonribosomal synthetic processes. This new class of
protein has excited interest as cyclization of a protein backbone has the
potential to provide stabilization relative to conventional proteins, both
in a thermodynamic sense (2) and biologically (3). Because circular pro-
teins have no termini, they have no target sites for amino- or car-
boxypeptidases. Furthermore, because the termini of conventional pro-
teins are often flexible, and the degree of flexibility can be reduced by
cyclization, entropic factors can lead to improved receptor binding
affinities of circular proteins over corresponding acyclic proteins. Thus,
circular proteins potentially have a range of advantages over conven-
tional proteins and may find interesting applications in protein engi-
neering, agriculture, and drug design (4).
SFTI-12 is a 14-amino-acid, backbone-cyclized protein found in the
seeds of Helianthus annus (sunflower), which possesses potent trypsin
inhibitory activity as well as weaker inhibitory activity against proteases
such as thrombin (5, 6). Based on sequence homology, SFTI-1 appears
to be related to the Cys-rich trypsin inhibitors called the Bowman-Birk
inhibitors (BBIs) that are widely distributed within plants of the
Fabaceae (leguminous) and Poaceae (graminaceous) families (7, 8). Two
classes of BBIs have been identified as follows: the first class, found in the
Poaceae, possessing a single active site, and the second class, found in
both plant families, possessing two active sites that are capable of inhib-
iting both chymotrypsin and trypsin simultaneously in a 1:1:1 stoichi-
ometry (9, 10). SFTI-1 appears to be a natural peptide mimetic of the
BBIs as it shares strong sequence and structural homology with the
trypsin inhibitory loop of the BBI family (Fig. 1) (6, 11). Remarkably,
despite strong sequence and structural conservation, SFTI-1 has only
been found in the seeds of the sunflower, which, as a member of the
Compositae, is phylogenetically removed from other plant families con-
taining BBIs. Furthermore, no other proteins sharing similarity with the
BBIs have been identified in the Compositae (12), suggesting that
SFTI-1 is restricted to a single, phylogenetically isolated species.
Two other classes of cyclic proteins have been discovered in the plant
kingdom, namely the cyclotides (13) and the cyclic knottins (3, 14), but
only the cyclotides have been characterized at a genetic level to reveal
their linear precursor (15, 16). The conservation of key residues, partic-
ularly Asn and Asp residues, in the cyclotide precursor has led to the
suggestion that proteases such as asparaginyl endoproteases are
involved in the cyclization reaction (13, 15). The involvement of pro-
teases in cyclization has been further suggested by the report of in vitro
cyclization of linearized SFTI-1 with trypsin (17) and the characteriza-
tion of the biosynthetic pathway of the cyclic sex pilin subunit TrbC. In
the pilin system a serine protease-like enzyme, TraF, mediates both the
cleavage of the TrbC precursor and the subsequent ligation of theN and
C termini via aminolysis of an acyl intermediate (18–20). Both of these
reactions rely on the presence of certain residues, and if the in vivo
cyclization of plant proteins proceeds via a protease-catalyzed path,
then the determination of precursor sequences for all classes of plant-
cyclized proteins is of paramount importance for understanding the
cyclization mechanism.
To date, nothing is known about the biosynthetic pathway of SFTI-1,
* This work was supported by a grant (to D. J. C.) from the Australian Research Council.
The costs of publication of this article were defrayed in part by the payment of page
charges. This articlemust therefore be herebymarked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
Theatomic coordinates and structure factors (code2AB9)havebeendeposited in theProtein
DataBank, ResearchCollaboratory for Structural Bioinformatics, RutgersUniversity, New
Brunswick, NJ (http://www.rcsb.org/).
1 Australian Research Council Professional Fellow. To whom correspondence should be
addressed: Institute forMolecular Bioscience, TheUniversityofQueensland, Brisbane,
Queensland 4072, Australia. Tel.: 61-7-3346-2019; Fax: 61-7-3346-2029; E-mail:
d.craik@imb.uq.edu.au.
2 The abbreviations used are: SFTI-1, sunflower trypsin inhibitor 1; BBI, Bowman-Birk
inhibitor; RE, regular expression; EST, expressed sequence tag; RP-HPLC, reverse
phase-highpressure liquid chromatography; NOE, nuclearOverhauser effect; NOESY,
nuclear Overhauser effect spectroscopy; TOCSY, total correlation spectroscopy; PDB,
protein data bank; r.m.s.d., root mean square deviation.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 280, NO. 37, pp. 32245–32253, September 16, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
SEPTEMBER 16, 2005•VOLUME 280•NUMBER 37 JOURNAL OF BIOLOGICAL CHEMISTRY 32245
 at UQ Library on October 10, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and a number of possibilities has been suggested (21), namely that it is
nonribosomally produced in a fashion analogous to nonribosomally
produced proteins in bacteria, that it is expressed as a larger protein,
which may or may not bear resemblance to the BBIs, or that it is
expressed as a 14-amino acid protein that is consequently cyclized. A
resolution of this problem has been hampered by the small size of
SFTI-1, which restricts the usefulness of PCR approaches due to the
limited sequence available for degenerate primer design and the dimin-
utive product produced. Furthermore, the cyclic nature of SFTI-1 com-
plicates primer design because the order in which residues appear in the
linear precursor is unknown. Because SFTI-1 is expressed only in seeds,
isolation of cDNA containing the SFTI-1 transcript is also problematic
due to the unknown timing of its expression. Accordingly, in this work,
an approach utilizing bioinformatics and data base screening was per-
ceived to be themost appropriate, andmost likely to succeed,method of
determining the sequence of the SFTI-1 precursor.
In this paper the sequence and structure of the linear precursor of
SFTI-1 is reported. The mature peptide was first reported in 1999, but
until now it was not known whether it was a gene product or nonribo-
somally produced. The presence of a linear precursor in the sunflower
suggests that SFTI-1 is gene-expressed, and the sequence of the 52-a-
mino acid precursor that is processed into mature cyclic SFTI-1 shares
interesting parallels with the cyclotides, the largest known family of
naturally occurring circular proteins. The structure reported here
shows that the major structural elements of the reactive site loop of
SFTI-1 are present before processing, whereas the precursor region
adopts amuch greater degree of conformational freedom.The sequence
of the precursor further indicates that, apart from the reactive site loop,
SFTI-1 does not bear any further resemblance to the BBIs.
EXPERIMENTAL PROCEDURES
Regular Expression Searches—For regular expression searching of the
sunflower data base, a regular expression (RE) coding for the active site
residues (CTKSIPPIC) was generated. For searching of the Arabidopsis
genomic data base, a regular expression was generated coding for the
active site residues of known dicot BBIs (Fig. 2). The scripting language
PERLwas used to search flat file data bases ofDNA sequences in FASTA
format for protein patterns corresponding to the regular expressions.
The script used the BioPERL modules to translate each sequence in six
reading frames and these translations were searched for the particular
regular expression. If a match was made then the script returned the
pattern found as well as 20 residues on either side of the pattern. If the
data base being searched contained EST sequences, then the results
were filtered by examining the preceding 20 amino acids for stop codons
and discarding hits if these elements were present. The remaining hits
were then analyzed manually using GENSCAN and SignalP. If a
FIGURE 1.A ribbon depiction of the structure of
a BBI from Glycine max (soybean, PDB code
1BBI) with the chymotrypsin and trypsin-reac-
tive loops highlighted is shown. The detailed
structure of the trypsin inhibitory loop is shown
below the ribbon diagram and alongside the solu-
tion structure of SFTI-1 (PDB code 1JBL). In both
cases theCys residues and the lysine residue in the
P1 position (45) are highlighted with the side
chains depicted in stick form. The inset shows
SFTI-1 (PDB code 1JBL) superimposed with the
reactive loops of BBIs frommung bean (PDB code
1SMF), adzuki bean (PDB code 1TAB), and soybean
(PDB code 1BBI). For orientation purposes, the Cys
residues have been labeled on SFTI-1.
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genomic data base was being examined, then the contig containing the
hit was retrieved and analyzed using GENSCAN; if the hit was recog-
nized as an open reading frame, it was further analyzed with SignalP. By
using this procedure, searches were made by utilizing the SFTI-1 active
site RE and the BBI trypsin-reactive loop RE on a sunflower EST data
base and the complete genome sequence data bases of Arabidopsis.
The sun-QH-All-Phred sunflower data base was downloaded from
the Compositae Genome Project Data base (cgpdb.ucdavis.edu/), and
the genome sequence data base for Arabidopsis was downloaded from
the Tair website (www.arabidopsis.org/index.jsp).
Genomic PCRAnalysis—DNAwas isolated from sunflower seedlings
using the Nucleospin Plant kit from Machery-Nagel. This DNA was
used in the PCR using primers (Proligo Australia Pty. Ltd., Lismore,
New South Wales, Australia) designed from the data base hit. The for-
ward primer coded for the sequence MATTMAK (5-ATGGCAAC-
CACAATGGCA-3), and the reverse primer coded for the sequence
KSIPPIC (5-AAATCGGGGGAATCGACTTA-3). PCR products
were excised from agarose gel and cloned into pCR2.1-TOPO vector
using Invitrogen TOPO cloning kit for sequencing.
High Pressure Liquid Chromatography—Preparative reverse phase-
high pressure liquid chromatography (RP-HPLC) was performed on a
Waters 600-MS controller system equipped with a Waters 484 tunable
absorbance detector. Samples were manually loaded onto a Vydac C18
column (22 250mm, 300-Å pore size, 10-mparticle size) and eluted
at a flow rate of 8 ml/min with a linear gradient of 0–80% Buffer B (90%
HPLC grade acetonitrile in H2O, 0.05% trifluoroacetic acid) for 80 min
with UV detection at 230 nm. Semipreparative RP-HPLC was per-
formed using the same conditions and equipment with a Vydac C18
column (10 250mm, 300-Å pore size, 10-mparticle size) and a flow
rate of 3 ml/min. Analytical RP-HPLC was performed on a Waters 600
controller system equipped with a Waters 486 tunable absorbance
detector. Samples were auto-injected using a Waters 717plus onto a
Vydac C18 analytical column (4.6  250 mm, 300-Å pore size, 5-m
particle size). Sampleswere eluted at a flow rate of 1ml/minwith a linear
gradient of 0–80% Buffer B for 40 min with UV detection at 215 nm.
Mass Spectrometry—Allmass data were obtained using electrospray/
time of flight mass spectrometry on a Mariner instrument (PerSeptive
Biosystems). A 25-l sample was injected into an Applied Biosystems
140B solvent delivery systemandpassed through themass spectrometer
at a flow rate of 80 l/min with a constant organic solvent ratio of 80%
Buffer B. Protein mass peaks were recorded in the linear mode between
1,000 and 25,000m/z with a step size of 0.1 or 0.2 Da and a delay time
of 0.3 s. The nozzle potential was set between 60 and 100 V, and data
were acquired as [M  2H]2 and processed using Biospec Data
Explorer 3.0.0.0 (PerSeptive Biosystems) software.
Expression of Pro-SFTI-1—The PCR was used to amplify pro-SFTI-1
from sunflower DNA using the same procedure as above. The forward
primer in this reaction coded for the sequenceGYKTSISwith a SapI site
included at the 5 end (5-GCTCTTCCAACGGTTACAAAACCTC-
TATCTC-3) and the reverse primer coded for the sequence PDGRP*
and included a PstI site at the 5 end (5-CTGCAGTTATGGCCTGC-
CATCGGGA-3). The PCR product was excised from agarose gel and
cloned into pTWIN1 to produce a plasmid encoding pro-SFTI-1 N-ter-
minally fused to the intein. This plasmid was transformed into Esche-
richia coli (strain ER2566) and was then grown in LB medium contain-
ing 100 g/ml ampicillin to an A600 of 0.5. Protein expression was
induced by the addition of isopropyl 1-thio--D-galactopyranoside to a
final concentration of 0.5 mM, and the culture was incubated overnight
at 15 °C.
After incubation the cells were harvested by spinning at 5000 g for
15 min at 4 °C. The cell pellet was resuspended in Buffer B1 (20 mM
Tris-HCl, pH 8.5, containing 500 mM NaCl, 1 mM EDTA, and 20 M
phenylmethylsulfonyl fluoride) and lysed by sonication. This mixture
was centrifuged at 19,000 g for 30 min, and 40 l of the supernatant
was analyzed by using SDS-PAGE to confirm the presence of the fusion
protein in the soluble fraction. A column was packed with 10 ml of
chitin beads, equilibrated with 10 bed volumes of Buffer B1 at 4 °C, and
the supernatant loaded at1 ml/min. The column was washed with 10
bed volumes of Buffer B1. On column cleavage of the intein fusion
protein was induced by overnight incubation of the column in Buffer B2
(20mMTris-HCl, pH 7.0, containing 500mMNaCl, 1mMEDTA, and 20
M phenylmethylsulfonyl fluoride) at room temperature, and pro-
SFTI-1 was eluted with Buffer B1. The eluant was further purified using
preparative HPLC, and the presence of pro-SFTI-1 was confirmed by
using mass spectrometry. The peak containing pro-SFTI-1 was lyophi-
lized yielding dry peptide.
Synthesis of Pro-SFTI-1—The SFTI precursor was assembled using
manual solid phase peptide synthesis with t-butoxycarbonyl/O-benzo-
triazole-N,N,N,N-tetramethyluronium hexafluorophosphate chemis-
try on a 0.5 mM scale. The C-terminal proline was attached to the resin
via a 4-(oxymethyl)-phenylacetimido-methyl linker (t-butoxycarbonyl-
Pro-4-(oxymethyl)-henylacetimido-methyl resin 100–200mesh,Nova-
biochem), and amino acids were added to the resin by using O-benzo-
triazole-N,N,N,N-tetramethyluronium hexafluorophosphate with in
situ neutralization. Cleavage of the peptide from the resin was achieved
using hydrogen fluoride with p-cresol and p-thiocresol as scavengers
(9:0.5:0.5 (v/v) hydrogen fluoride/cresol/thiocresol). The reaction was
allowed to proceed at5 to 0 °C for 90 min. The hydrogen fluoride was
removed, and the peptide was precipitated with diethyl ether. After
filtration, the peptide was solubilized in 50% Buffer A (0.05% trifluoro-
acetic acid/water)/Buffer B (90% acetonitrile/0.05% trifluoroacetic acid/
water) and lyophilized. The crude peptide was initially purified using
preparative HPLC followed by semi-preparative HPLC. Mass spec-
trometry was used to identify peaks containing pro-SFTI-1.
Purified pro-SFTI-1 was oxidized in ammonium carbonate with and
without glutathione. In the former reaction, pro-SFTI-1 was incubated
overnight in 0.1 M ammonium carbonate at room temperature. In the
latter, pro-SFTI-1 was incubated overnight at room temperature in 0.1
M ammonium carbonate with 10 mM reduced glutathione and 1 mM
oxidized glutathione. The products were purified with semi-preparative
HPLC, and the correct peak was identified by using mass spectrometry.
NMR Spectrometry and Structure Calculations—Approximately 2
mg of dry pro-SFTI-1 was dissolved in 550 l of 90% H2O, 10% D2O
(99.9%, Cambridge Isotope Laboratories, Woburn, MA). Spectra were
recorded at 295, 298, and 305 K on a Bruker Avance-600 NMR spec-
trometer. All two-dimensional spectra were recorded in phase-sensitive
mode using time-proportional phase incrementation for quadrature
detection in the t1 dimension (22). Two-dimensional experiments per-
formed included a DQF-COSY (23), a TOCSY (24) with a mixing time
of 80 ms, an ECOSY (25) and NOESY spectra (26) with mixing times of
100, 150, and 200 ms. Solvent suppression for NOESY and TOCSY
experiments was achieved using a modified WATERGATE sequence
(27). For the DQF-COSY experiment, the water signal was suppressed
by lower power irradiation during the relaxation delay (1.8 s). Spectra
were routinely acquired over 8802 Hz with 4096 complex data points in
F2 and 512 increments in the F1 dimension, with 40 scans per increment
(96 for NOESY). A series of one-dimensional and TOCSY spectra were
run immediately after dissolving the fully protonated sample in D2O for
identification of slowly exchanging amide protons.
Spectra were processed on a Silicon Graphics Indigo work station
using XWIN-NMR (Bruker) software. The t1 dimension was zero-filled
Linear Precursor of SFTI-1
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to 2048 data points, and shifted sinebell window functions were applied
prior to Fourier transformation. Chemical shifts were referenced to
2,2-dimethyl-2-silapentane-5-sulfonate sodium salt at 0.00 ppm. Two-
dimensional spectra were assigned using TOCSY cross-peaks for intra-
amino acid assignments and NOESY cross-peaks for sequential assign-
ment (28). Spectra were analyzed with the program SPARKY (29).
The intensities of cross-peaks in NOESY spectra with a mixing time
of 100 ms were calibrated, and distance constraints were derived using
CYANA (30). Corrections for pseudoatomswere added to distance con-
straints where needed (31). Backbone dihedral angle restraints were
derived from 3JHNH coupling constantsmeasured from line shape anal-
ysis of antiphase cross-peak splitting in the DQF-COSY spectrum.
Angles were restrained to 120° 40° for 3JHNHa 9 Hz. Positions of
slowly exchanging amides were analyzed within preliminary structures,
and in two cases hydrogen bonds were unambiguously assigned and
added to the restraints. After initial structure calculations using
CYANA, sets of 50 structures were calculated using a torsion angle
simulated annealing protocol within CNS (32). The resulting structures
were subjected to furthermolecular dynamics and energyminimization
in a water shell (33). The final ensemble of 20 structures was deposited
in the PDB as 2AB9.
Platelet Aggregation Assays—Platelet aggregation assays were per-
formed using human platelet-rich plasma by drawing blood from a
human volunteer who had not had aspirin or related products for at
least 14 days. The aggregation assay was performed by adding 50 l of a
0.6 mM solution of cyclic SFTI-1 to 400 l of platelet-rich plasma at
37 °C.After incubation for 5min 25l of 0.2mMadenosine diphosphate
was added and the light transmittance recorded.
RESULTS
Regular Expression Searching—SFTI-1 contains only 14 amino acids,
of which only seven share sequence identity with the BBIs. Accordingly,
BLAST searches are ineffective when searching for homologous
sequences due to the short query sequence. Hence, to locate proteins
that contain sequence identity to the active site of SFTI-1 and the Bow-
man-Birk inhibitors, the RE capabilities of the Perl scripting language
were used to examine various plant data bases. Using the sequence of
SFTI-1 and the active site residues of known Bowman-Birk inhibitors,
an RE was generated that coded for the seven-residue loop that consti-
tutes the active site in SFTI-1 and the BBIs (Fig. 2). This RE was used in
a Perlscript that translated each data base entry in six reading frames
and searched each translation for the pattern specified in the RE. By
utilizing this approach, it was hoped that both the precursor of SFTI-1
would be identified in sunflower sequence data bases and that peptides
similar to SFTI-1 would be identified in the model plant Arabidopsis.
The search of the Arabidopsis genome yielded no significant hits using
the RE, but the same search of a sunflower EST data base produced a
significant hit for a gene that encoded the full sequence of mature
SFTI-1 embedded in a 52-amino acid precursor protein.
Description of Identified Genes—Fig. 3 sets out the putative precursor
of SFTI-1, denoted prepro-SFTI-1, identified in RE searches of the sun-
flower EST data base. The program SignalP (34) was used to identify
signal sequence, and output from this program suggested that the pre-
cursor contains a 21-amino acid N-terminal signal sequence. Following
the signal sequence, a 14-amino acid pro-peptide precedes the 14 amino
acids that putatively constitute the mature SFTI-1 sequence. The
mature sequence is followed by a three-residue tail. Most interestingly,
the first two residues of this short tail (Gly-Arg) are the same as the first
two N-terminal residues of the mature sequence. Consequently, the
exact processing points of SFTI-1 cannot be identified. As processing of
SFTI-1 from this precursor must include two proteolytic cleavages at
the N and C termini prior to cyclization, these cleavages can occur at
three separate positions to produce the same cyclic peptide (see Fig. 3).
As an aside, this highlights the “seamlessness” of backbone cyclization as
a post-translational modification and mirrors the situation in the
cyclotides, in which the linear precursors coded in the Oak1, Oak2, and
Oak3 clones could in principle be processed in four different positions
to produce the same cyclic peptide (15).
To confirm the presence of the data base hit in the sunflower, genome
primers were designed for the upstream region of the data base hit and
for a regionwithin themature SFTI-1 sequence. The PCRwas then used
to amplify the gene from sunflowerDNA.The PCRproduced two bands
of150 and 1000 bp. Both of these bandswere excised from the agarose
gel and cloned for sequencing. The smaller band contained the same
sequence predicted by the data base mining, but the larger band con-
tained sequence coding for the beginning of the gene in one reading
frame, a large insert, and the end of the gene in a different reading frame.
Accordingly, it would appear that the sunflower genome contains a
FIGURE 2. An alignment of the active site residues from SFTI-1 and various BBIs;
mung bean trypsin inhibitor (PDB code 1SMF), adzuki bean trypsin inhibitor (PDB
code1TAB), andsoybeantrypsin inhibitor (PDBcode1BBI).Theconsensus sequence
for dicot BBIs is givenbelow the alignment andwasderived fromdata in Ref. 8. The active
site nomenclature of Schechter and Berger (45) is displayed at the bottom of the align-
ment.
FIGURE3.Thesequenceof the52aminoacidprepro-SFTI-1asderived fromthedata
basehit (top).Apredictedendoplasmic reticulumsignal region is shown in theblackbox
and the putative mature peptide in the white box. In order to produce cyclic SFTI-1 the
precursor must be cleaved at the N-terminal and the C-terminal, but the repeat of a
Gly-Arg motif at either end of the mature sequence provides three different cleavage
combinations (middle) to produce the same cyclic peptide (bottom). This is similar to the
situation encountered in the Oak clones from O. affinis (15).
Linear Precursor of SFTI-1
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complete SFTI-1 precursor gene, as well as one that has been destroyed
some time in the past by an insertion. The presence of a short repeat
(CTAAG) at either end of the insertion suggests that the insertion was
the result of transposon activity.
Expression and Synthesis of Pro-SFTI-1—By using the output of Sig-
nalP, the signal sequence of the identified prepro-SFTI-1was deemed to
end immediately prior to Gly22. To obtain a correctly folded sample of
the pro-peptide, two approaches were utilized. First, pro-SFTI-1 was
synthesized using solid phase chemistry and oxidized in ammonium
carbonate in two reactions with andwithout glutathione. For both reac-
tions, RP-HPLC and electrospray/time of flight mass spectroscopy was
used to separate themajor isoform fromminor peaks. Second, the same
sequence was cloned into pTWIN1 and expressed in E. coli as an N-ter-
minalmini-intein fusion protein incorporating a chitin binding domain.
Expressed pro-SFTI-1 was then loaded onto a chitin column and auto-
catalytically cleaved from themini-intein tag using a combination of pH
and temperature. Once again RP-HPLC and electrospray/time of flight
mass spectroscopy was used to purify pro-SFTI-1. Analysis of all sam-
FIGURE 4. A, summary of the short and medium range NOEs, coupling constants, and slowly exchanging amide protons for pro-SFTI-1. Slowly exchanging NH protons (observed in
TOCSY spectra recorded in 2H2O) are indicated by filled circles. Residues with a
3JHNH coupling constant greater than 8.5 Hz aremarkedwith an1. Below the coupling constant row
is a summary of sequential andmedium rangeNOE connectivities. Filled bars indicate sequential connections, and theheight of thebar indicates the strength of theNOE. B,deviation
of theH chemical shifts fromrandomcoil values for each residue inpro-SFTI-1.C, schematic representationof the-sheet regionofpro-SFTI-1. InterstrandNOEsare shownasarrows;
slowly exchanging amide protons (after dissolution in 2H2O) are indicated with an asterisk, and potential hydrogen bonds are depicted with broken dashes. Sequential NOEs are not
shown for clarity, apart fromanH-HNOE that is consistentwith a cispeptidebondbetween residues 21 and22. An expectedNOEbetween Ile21HNandPro23H thatwas obscured
by overlap is shown with awavy line.
Linear Precursor of SFTI-1
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ples with analytical RP-HPLC and mass spectrometry showed that all
samples possessed the correct mass and the same elution time under
similar conditions.
1H NMR Resonance Assignments—Pro-SFTI-1 was dissolved in
water, and NMR spectra were recorded. The amino spin systems were
identified using TOCSY and DQF-COSY spectra recorded at 298 K.
Despite some overlap in the precursor region between residues 1 and 14,
complete sequential assignments weremade using TOCSY andNOESY
spectra recorded at 298, 295, and 307 K. The difference between the
secondary shifts of the backbone H protons of the individual spins
systems and the H chemical shift of the same residue in a random coil
peptide is a guide to the secondary structure present in a particular
protein (35). When combined with short and medium range NOEs,
coupling constants, and slowly exchanging amide protons, an indication
of themajor forms of secondary structure can be derived. A summary of
this information for pro-SFTI-1 is presented in Fig. 4.
The major form of secondary structure in pro-SFTI-1 is a short well
defined antiparallel -sheet between residues 17 and 26 with a turn
centered on Ile21. A series of positive secondary shifts is generally indic-
ative of extended structure, and positive shifts between Arg16–Lys19
and, to a less extent, Cys25–Phe26 suggest that these residues comprise
two parts of the antiparallel sheet. This is supported by the pattern of
inter-strand NOEs and large coupling constants for residues Cys17 and
Ile24. Analysis of slow exchanging amide protons indicates that main
chain hydrogen bonds predicted for this conformation are present
between Thr18HN and Ile24O as well as Phe26HN and Arg16O. A bifur-
cated hydrogen bond between the side chain carboxyl of Thr18 and the
backbone amides of Ser20 and Ile21 has been identified in cyclic SFTI-1
(6, 11), and the presence of slowly exchanging amide protons in these
residues is consistent with the presence of the same arrangement in
pro-SFTI-1. Furthermore, the presence of a strong NOE between the
Hprotons of Ile21 and Pro22 indicates that this peptide bond is in the cis
conformation which is typical of SFTI-1 (6, 11) and dicot BBIs (21).
Overall the secondary structure predicted here is consistent with the
secondary structure of the mature cyclic SFTI-1 and indicates that the
active site loop of pro-SFTI-1 adopts a similar structure to cyclic SFTI-1.
As mentioned above, assignment of the spectra for pro-SFTI-1 was
complicated by overlap in residues comprising the precursor region of
the protein. Furthermore, only sequential NOEs were identified in this
region with no long or medium range interactions seen in the spectra,
suggesting that this part of the protein is essentially unstructured. Con-
firmation of the unstructured nature of the precursor region was
achieved by analysis of secondary H chemical shifts for residues 1–13.
Fig. 4 shows that, with the exception of Gly1 and Asp13, the shifts do not
depart from random coil values by more than 0.1 ppm, indicating that
the precursor region of pro-SFTI-1 contains no defined secondary
structure and is essentially random coil.
Three-dimensional Structure—A set of 50 structures was calculated
by simulated annealing using 115 inter-residue NOE distance restraints
and 10 dihedral angle restraints. As predicted by analysis of the second-
ary H shifts, NOE connectivities, and slowly exchanging amides, the
structure of pro-SFTI-1 has a poorly defined region between residues 1
FIGURE 5. A, stereoview of the well defined reactive site loop of pro-SFTI-1 (PDB ID 2AB9). Residue numbers are indicated on the left-hand view. B, ribbon diagram of pro-SFTI-1
showing the two-stranded-sheet and short tail. ThedisulfidebondbetweenCys17 andCys25 is depicted inball and stick. C, the20 lowest energy structuresof pro-SFTI-1 alignedover
the reactive site loop. The disorder in the precursor region is clearly visible.
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and 16, a well defined domain between residues 17 and 25, and a flexible
tail region. Fig. 5 shows the three-dimensional structure of pro-SFTI-1,
including a superimposition of the 20 lowest energy structures after
energy minimization in a water box. Residues 17–25 correspond to the
reactive loop ofmature SFTI-1, and over this region the structures show
excellent convergence with an r.m.s.d. of 0.28 0.11 Å over backbone
atoms and 1.18 0.31 Å for all heavy atoms. There was no divergence
from ideal covalent geometry in this region. Over the whole molecule
the structures fit the experimental restraints with minimal violations.
There were five NOE violations greater than 0.2 Å (largest 0.25 Å) and
no dihedral angle restraint violations greater than 2° present in the set of
lowest energy structures. A summary of the structural statistics is given
in TABLE ONE.
Analysis of the 20 lowest energy structures with PROMOTIF indi-
cates that the major structural elements are two -strands joined by
a type IV -turn in the region corresponding to the reactive site loop.
The absence of any NOE connectivities between the precursor
region and the well defined domain of pro-SFTI-1 indicates that this
region is essentially extended away from the -sheet, and the local
r.m.s.d. for residues 1–16 is increased significantly, reflecting the
lack of short and long range NOE restraints. The tail of the molecule,
between residues 26 and 31, also exhibits an increase in local r.m.s.d.,
although the presence of NOE interactions between the side chain of
Arg30 and Pro22 suggests that it may have a tendency to fold back
over the -sheet region.
Platelet Aggregation Assays—Themature sequence of SFTI-1 con-
tains a reverse RGD sequence. To investigate the possibility that
cyclic SFTI-1 interacts with integrin receptors, platelet aggregation
assays were conducted on mature cyclic SFTI-1. No inhibitory activ-
ity was shown, implying that cyclic SFTI-1 does not interact with
integrins.
DISCUSSION
Themechanism, or mechanisms, by which linear precursors are pro-
cessed into cyclized proteins in the plant kingdom is still poorly under-
stood. The linear precursors of only one class of plant cyclic peptide,
namely the cyclotides, have been identified (15, 16), but the mechanism
of cyclization remains unknown. The work presented here demon-
strates that SFTI-1 is derived from a 52-amino acid, gene-expressed
precursor protein and that the major structural elements of mature
SFTI-1 are present in the precursor. Additionally, certain sequence sim-
ilarities between this precursor and the linear precursor of the cycloti-
des suggest that a similar mechanism of cyclization operates in both
plant species. The phylogenetic isolation of SFTI-1 from its BBI cousins
is further confirmed in this study and raises interesting questions
regarding the evolution of this fascinating circular peptide.
Structural Comparison of Pro-SFTI-1 with SFTI-1 and BBI Active Site
Loops—The family of structures of pro-SFTI-1 shows high convergence
in the region of the molecule corresponding to the reactive site loop of
mature cyclic SFTI-1. As is the case with cyclic SFTI-1, the major struc-
tural element is a short two-stranded -sheet, although in pro-SFTI-1
this -sheet is truncated to the region about the disulfide bonds. Out-
side of this region, particularly in the precursor region, the molecule is
essentially unstructured. The structure of the reactive site loop in pro-
SFTI-1 adopts a similar conformation to the corresponding region in
cyclic SFTI-1 and the trypsin inhibitory loop of the BBIs. This structural
similarity can clearly be seen in Fig. 6, which depicts a superimposition
of the reactive loops from pro-SFTI-1, cyclic SFTI-1, and the trypsin
inhibitory loop of the soybean BBI. The backbone r.m.s.d. between the
three molecules over this region of 0.65 Å underscores the structural
resemblance.
Given the similarity in the reactive site loop between pro-SFTI-1 and
cyclic SFTI-1, it is likely that this region also exhibits the conformational
rigidity shown by cyclic SFTI-1. The existence of slowly exchanging
amides in residues 18, 20, 21, 24, and 26 and the pattern of NOE con-
TABLE ONE
Geometric and energetic statistics for pro-SFTI-1
The values are given as mean S.D. for the ensemble of the 20 final solution
structures. Experimental distance restraints include only interresidual NOEs.
Energies (kcal mol1)
Overall 961.05 35.28
Bonds 6.79 0.95
Angles 35.09 7.85
Improper 4.51 1.31
van der Waals 21.44 13.78
NOE 7.23 2.40
cDih 0.06 0.06
Dihedral 98.11 8.20
Electrostatic 1091.41 43.20
r.m.s.d.
Bond (Å) 0.004 0.0002
Angle (°) 0.51 0.05
Improper (°) 0.35 0.05
NOE 0.03 0.006
cDih 0.26 0.20
Pairwise r.m.s.d. (Å)a
Backbone/heavy 0.28 0.11
1.18 0.31
Experimental data
Distance restraints 115
Dihedral restraints 10
NOE violations exceeding 0.20 Å 5 (largest 0.25)
cDih violations exceeding 2.0 0
Ramachandrana
Most favored 76.00%
Additionally allowed 24.00%
Disallowed 0.00%
a Statistics quoted apply only to the defined reactive site loop between residues 17
and 25.
FIGURE 6. Superimposition of the reactive site loops of pro-SFTI-1 (PDB ID 2AB9),
cyclic SFTI-1 (PDB ID1JBL), and the trypsin inhibitory loopof the soybeanBBI (PDB
ID 1BBI). Cys residues are highlighted, and the Cys numbering of pro-SFTI-1 is indicated
for reference.
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nectivities across the-sheet suggests that the network of cross-bracing
hydrogen bonds that stabilizes the reactive site loop of SFTI-1 is also
present in pro-SFTI-1. The structure reported here shows that the basic
structure of the reactive site loop of cyclic SFTI-1 has already taken
shape before the processing of the pro-peptide.
The sequence of prepro-SFTI-1 illustrates that the processing point
where the N and C termini of linear SFTI-1 are ligated is located in the
secondary loop. As would be expected, the structure of this loop is
greatly altered to accommodate the precursor region and the short tail
region. Although the presence of a GRmotif at either end of the mature
sequence makes the precise location of the processing points ambigu-
ous, it is clear that cleavage of pro-SFTI-1 will occur in unstructured
regions. A recent report suggested that protein digestion was enhanced
by the presence of unstructured regions (36), and the lack of structure in
the areas of pro-SFTI-1, in which cleavage must occur may, likewise
assists in the processing of the precursor.
Processing of Pro-SFTI-1—The only other linear precursor of cyclized
plant proteins that has been characterized is that of the cyclotides. In
this case the presence of a conserved Asn/Asp at the C-terminal proc-
essing point has led to the suggestion that asparaginyl proteases are
involved in the cyclization reaction (15). The members of this class of
protease, collectively known as legumains, are reported to cleave various
proteins in the secretory pathway by proteolytic cleavage on the C-ter-
minal side of Asn residues (37–39). Most interestingly, an asparaginyl
endopeptidase is also suspected of mediating a transpeptidation reac-
tion in the processing of the concanavalin A precursor in Canavalia
ensiformis (jack bean) (40). In this case the enzyme mediates the Asn-
specific excision and transpeptidation of the precursor to produce an
inversion of peptide fragments in the mature peptide.
As discussed above, there are three possible processing points that
could produce mature SFTI-1. One of these processing points would
require cleavage after Asn to form theN terminus and after Asp to form
the C terminus. It is possible that an asparaginyl protease couldmediate
both the cleavage of SFTI-1 from the precursor and the subsequent
ligation of the free termini at this position in the precursor. The two
other possible processing points involve cleavages after Gly or Arg res-
idues at both the N and C termini. Cleavage after Arg residues could be
mediated by trypsin or a trypsin-like enzyme. Although in that case
involving the scissile bond (Lys5–Ser6), the recent report (17) of the in
vitro cyclization of linearized SFTI-1 by trypsin suggests the involve-
ment of a similar mechanism in the biosynthesis of SFTI-1. It is thought
that the rigid structure of SFTI-1 prevents conformational change upon
linearization, and consequently the equilibrium of the catalyzed reac-
tion shifts toward the reformation of the peptide bond (17). Given that
the reactive site loop of pro-SFTI-1 is well defined prior to processing, it
is possible that after cleavage the linear form of SFTI-1 produced is
sufficiently rigid to allow a similar process to occur, in this case involving
an asparaginyl protease or a trypsin-like protease depending on the
exact location of the processing points.
Although the involvement of a protease is a compelling idea, it is also
possible that after cleavage of the precursor cyclization could proceed
via a succinimide or cyclic anhydride, to yield a cyclic peptide without
the need for a processing enzyme. Although a reaction such as this has
not been observed in vitro, the presence of an iso-Asp in SFTI-1 linear-
ized between Gly1 and Asp14 highlights the increased reactivity of this
location (17). If pro-SFTI-1 is cleaved after Asn14N-terminally and after
Asp28 C-terminally then the reactivity of this site could mediate the
autocatalytic ligation of the free termini, thus obviating the need for a
cyclizing enzyme.
SFTI-1 and the BBIs—The sequence reported here also demonstrates
that, apart from the reactive loop residues, SFTI-1 does not appear to
share any other similarities with the BBIs. This rules out the possibility
that SFTI-1 is processed from a larger BBI-like protein but does not rule
out the possibility of an evolutionary relationship between the two
classes of protein. However, if SFTI-1 is evolutionarily related to its
larger cousins, then it would be reasonable to expect that other mem-
bers of the Compositae would contain SFTI-1 or BBI-like proteins. A
study of the protease content of seeds from the Compositae found no
BBI-like proteases in this family (12). Accordingly, if SFTI-1 and the
BBIs are related, then the gene has consequently been lost in all other
species from the Compositae. Despite this, it is intriguing that the study
of trypsin inhibitors in the Compositae did partially characterize an
unidentified trypsin inhibitor in Zinnia elegans with an Mr of 11,350
that shared limited homology with the BBIs (17). Likewise, a number of
trypsin inhibitorymolecules withmolecular weights of7600were also
identified in sunflower seeds but were not further characterized. In
principle these masses could represent BBI-like proteins, or descend-
ants of BBIs, within sunflower seeds. One possible hypothesis could be
the separate evolution of a single-headed BBI within the Compositae
from an ancestral single-headed monocot BBI. The single-headed vari-
ant is thought to be ancestral to modern BBIs (41), and derivation of
SFTI-1 from a single-headed descendant in the Compositae is certainly
possible.
A number of other explanations are possible to explain the phyloge-
netic isolation of SFTI-1. The reactive site loop of SFTI-1may represent
an example of convergent evolution. Another possibility is a domain
swap placing the reactive loop of a BBI into a novel precursor protein
(43) sometime prior to the divergence of the Compositae from the
Fabaceae. Although such events are not common (42), the repetition of
reactive domains in monocot and dicot BBIs shows that gene duplica-
tion is an active force in BBI evolution (8, 44), and displacement of the
reactive loop may have occurred through serendipity or by an as yet
unidentified mechanism. Finally, the reactive site loopmay be an exam-
ple of gene transfer; one conceivable mechanism by which such a proc-
ess could occur is via the accidental incorporation of the reactive site
loop into a viral DNA.
In conclusion, the field of backbone cyclized proteins has expanded
rapidly since the first discovery a decade ago, and the discovery of the
linear precursor of SFTI-1 offers an opportunity to better understand
the process by which these fascinating proteins are produced.
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